Researchers at Flinders University have introduced a mobile application that helps persons with attention deficit hyperactivity disorder to self-manage their condition.
Developed by their partner, Adelaide-based digital health company goAct, the prototype app provides short targeted questions at random times, psychoeducation tools, and treatment advice.
A companion clinical dashboard allows care...
Hopper Health, a healthcare navigation and virtual primary care platform, launched this week to provide care for adults with conditions like Tourette's, ADHD, autism and obsessive compulsive disorder.
Patients will have access to healthcare providers trained in the communication and sensory needs of the neurodivergent population.
The New York-based platform is directly available to consumers in...
Akili Interactive, the company behind a video game-like prescription digital therapeutic for children with ADHD, reported its first full-year earnings since going public last year.
The company reported $323,000 in revenue for 2022 compared with $538,000 for 2021. Akili said 2022 revenue was entirely made up of funds earned from sales of EndeavorRx, its therapeutic that received FDA clearance for...
Singaporean tech startup Neeuro and the Institute of Mental Health have unveiled their home-based attention training programme.
WHAT IT'S ABOUT
The digital therapeutic programme called Cogo seeks to solve inattentiveness in children aged 6-12 years through a 24-session guided game that is paired with the SenzeBand 2 EEG headband by Neeuro. It was developed based on Neeuro's Brain-Computer...
Akili Interactive hit the public markets in August, bringing in cash the company will use to launch its video game digital therapeutic for children with ADHD later this year.
Akili's product, dubbed EndeavorRx, is prescription software for kids ages 8 to 12 who have attention issues. It received FDA De Novo clearance in 2020 after years waiting for the agency green light, though a nonprescription...
Amid growing controversy over Cerebral's prescribing practices, the digital mental health company will pause prescriptions of controlled substances like Adderall and Ritalin for new patients.
The suspension will begin Monday, May 9, though existing patients can continue to receive their prescribed medications.
"It is regrettable that a helpful class of medication that is considered a first-line...
Akili Interactive, maker of a video game-based digital therapeutic for treating pediatric ADHD, announced Wednesday it plans to go public through a merger with special-purpose acquisition company Social Capital Suvretta Holdings Corp. I.
The deal is expected to net the digital therapeutics startup up to $412 million in gross cash proceeds, valuing the combined company at about $1 billion. The...
Seed funding of €2 million has been raised by medtech startup Inflow for its novel science-based app for ADHD patients, according to EU Startups.
Among the investors are Hoxton Ventures and Route 66 Ventures, along with angel investor Quit Genius.
WHY IT MATTERS
With the launch of their innovative app, the London-based founders Levi Epstein and Seb Isaacs want to enable ADHD patients to actively...
Mightier, a maker of a video game system intended to help children learn emotional regulation skills, scooped up $17 million in Series B funding.
The round was led by DigiTx Partners, with participation from the Sony Innovation Fund and PBJ Capital.
The Series B comes about two and half years after the Boston Children’s Hospital spin-out scooped up $6.6 million in Series A financing, followed by...
EndeavorRx, the FDA De Novo-authorized video game digital therapeutic for children with ADHD, is getting a slew of new gameplay features, its developer Akili Interactive announced today.
EndeavorRx takes the form of a game in which users navigate an alien avatar through a course while they respond to on-screen prompts. The app keeps track of movements, monitors the user’s behavior and quickly...
